Leerink Partners sets Pacira Biosciences price target at $28
Leerink Partners announced a $28.00/share price target for Pacira Biosciences (PCRX).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.